New immunization technologies, 12 clinical studies, 248 scientific publications, 6 patents: these numbers summarize the results of 6 years of work within the European research project ADITEC – Advanced Immunization Technologies, ending this year. The overall results of the project […]
The High Impact Project ADITEC, was launched in October 2011 to develop new vaccination strategies. The scope of the project, funded through the 7th Framework Programme for R&I of the European Union, was to accelerate the development of novel and […]
Recognizing some of the most significant medical discoveries from around the world, The Gairdner Foundation has awarded Dr. Rino Rappuoli, Chief Scientist and Head External R&D at GSK Vaccines, Siena, Italy, with the 2017 Canada Gairdner Award. One of seven […]
ADITEC is pleased to announce that the 2017 Albert B. Sabin Gold Medal award has been presented to Dr. Jan Holmgren for his pioneering contributions to oral vaccine research and mucosal immunology, as well as his leadership in the discovery […]
The ADITEC Project on Advanced Immunization Technologies: an European Success Story. 30 million Euros of funding, 42 public and private institutions have joined forces for next generation vaccines. The ADITEC project was presented today at the European Parliament as a […]